Evidence map›Paper›PMID 27930701›Full record

ArticlePloS one2016

Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation.

Olallo Sanchez, Oscar Campuzano, Anna Fernández-Falgueras, Georgia Sarquella-Brugada, Sergi Cesar, Irene Mademont, Jesus Mates, Alexandra Pérez-Serra, Monica Coll, Ferran Pico and 15 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Molecular autopsy for sudden death in Japan.Journal of toxicologic pathology · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Olallo SanchezCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Oscar CampuzanoCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).ORCID http://orcid.org/0000-0001-5298-5276
Anna Fernández-FalguerasCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Georgia Sarquella-BrugadaArrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona (Spain).
Sergi CesarArrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona (Spain).
Irene MademontCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Jesus MatesCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Alexandra Pérez-SerraCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Monica CollCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Ferran PicoCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Anna IglesiasCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Coloma TirónCardiovascular Genetics Unit, Hospital Josep Trueta, Girona (Spain).
Catarina AllegueCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Esther CarroArrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona (Spain).
María Ángeles GallegoForensic Pathology Service, Institut Medicina Legal Ciències Mèdiques Catalunya, Barcelona (Spain).
Carles Ferrer-CostaGendiag SL, Barcelona (Spain).
Anna HospitalForensic Pathology Service, Institut Medicina Legal i Ciències Forenses de Catalunya, Girona (Spain).
Narcís BardaletForensic Pathology Service, Institut Medicina Legal i Ciències Forenses de Catalunya, Girona (Spain).
Juan Carlos BorondoHistopathology Unit, Instituto Nacional de Toxicología y Ciencias Forenses, Barcelona (Spain).
Albert VingutHistopathology Unit, Instituto Nacional de Toxicología y Ciencias Forenses, Barcelona (Spain).
Elena ArbeloArrhythmia Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona (Spain).
Josep BrugadaArrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona (Spain).
Josep CastellàForensic Pathology Service, Institut Medicina Legal Ciències Mèdiques Catalunya, Barcelona (Spain).
Jordi MedalloForensic Pathology Service, Institut Medicina Legal Ciències Mèdiques Catalunya, Barcelona (Spain).
Ramon BrugadaCardiovascular Genetics Center, University of Girona-IDIBGI, Girona (Spain).
Universitat de Girona · ESHospital Sant Joan de Déu Barcelona · ESInstituto Nacional de Toxicología y Ciencias Forenses · ESHospital Clínic de Barcelona · ESHospital Universitari de Girona Doctor Josep Trueta · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSudden unexplained death may be the first manifestation of an unknown inherited cardiac disease. Current genetic technologies may enable the unraveling of an etiology and the identification of relatives at risk. The aim of our study was to define the etiology of natural deaths, younger than 50 years of age, and to investigate whether genetic defects associated with cardiac diseases could provide a potential etiology for the unexplained cases. METHODS AND

findingsOur cohort included a total of 789 consecutive cases (77.19% males) <50 years old (average 38.6±12.2 years old) who died suddenly from non-violent causes. A comprehensive autopsy was performed according to current forensic guidelines. During autopsy a cause of death was identified in most cases (81.1%), mainly due to cardiac alterations (56.87%). In unexplained cases, genetic analysis of the main genes associated with sudden cardiac death was performed using Next Generation Sequencing technology. Genetic analysis was performed in suspected inherited diseases (cardiomyopathy) and in unexplained death, with identification of potentially pathogenic variants in nearly 50% and 40% of samples, respectively.

conclusionsCardiac disease is the most important cause of sudden death, especially after the age of 40. Close to 10% of cases may remain unexplained after a complete autopsy investigation. Molecular autopsy may provide an explanation for a significant part of these unexplained cases. Identification of genetic variations enables genetic counseling and undertaking of preventive measures in relatives at risk.

Indexed as

Death, SuddenPostmortem ChangesAdultCohort StudiesFemaleHumansMaleMiddle AgedYoung Adult

Identifiers

PMID27930701
PMCPMC5145162
OpenAlexW2560410385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.